Albertsons Companies, INC
Market Movers (8-K)
NYSE
Albertsons reported a 0.8% decrease in identical sales for Q1 Fiscal 2026, with digital sales up 13%, while announcing a strategic realignment called ACI Edge to improve execution.
Worse than expected
NYSE
Albertsons Companies announced that President and Chief Financial Officer Sharon McCollam plans to retire later this year, with a transition period extending to February 27, 2027.
NYSE
Albertsons Companies announced fourth quarter and full year fiscal 2025 results, a 13% increase in its quarterly dividend, and a framework to resolve opioid-related claims for approximately $774 million.
NYSE
Albertsons Companies has appointed Brian Rice, McDonald's Global Chief Information Officer, to its Board of Directors, expanding the board to 11 members.
NYSE
Albertsons Companies successfully refinances $2.1 billion in senior notes, extending debt maturities to 2032 and 2034 while adjusting interest rates.
Capital raise
NYSE
Albertsons Companies announced a significant debt refinancing, issuing $2.1 billion in new senior notes to redeem existing 2027 and 2028 notes.
Capital raise
Quarterly Earnings (10-Q)
NYSE
Albertsons reported a slight decrease in net sales and other revenue for Q1 2026, with identical sales declining 0.8%, but saw a 13% increase in digital sales.
Worse than expected
NYSE
Albertsons Companies reports a 1.9% increase in net sales and other revenue for Q3 fiscal 2025, driven by strong digital and pharmacy growth, despite ongoing legal challenges and a decline in net income.
Worse than expected
Capital raise
Delay expected
NYSE
Albertsons Companies reports a 2.0% increase in net sales and other revenue for Q2 fiscal 2025, driven by strong pharmacy and digital sales growth, despite a decline in gross margin rate.
Delay expected
Worse than expected
NYSE
Albertsons Companies, Inc. reported a 2.5% increase in net sales driven by strong digital and pharmacy growth, but saw declines in net income and adjusted EBITDA, while navigating significant legal challenges including the terminated Kroger merger.
Worse than expected
NYSE
Albertsons reports a 2.0% increase in identical sales excluding fuel and a 23% jump in digital sales for Q3 2024, while also announcing the termination of its merger agreement with Kroger and a $2 billion share repurchase program.
NYSE
Albertsons Companies, Inc. reported a net income of $145.5 million for the second quarter of fiscal 2024, a decrease compared to the same period last year, while experiencing growth in identical and digital sales.
Worse than expected
Delay expected
Annual Reports (10-K)
NYSE
Albertsons Companies, Inc. reports fiscal 2025 financial results, highlighting a 2.0% increase in identical sales and a $773.8 million charge related to an opioid settlement framework.
NYSE
Albertsons Companies, Inc. reports a 2.0% increase in identical sales for fiscal 2024, driven by pharmacy and digital growth, despite the termination of its merger agreement with Kroger.
Worse than expected
NYSE
10-K: Albertsons Companies, Inc. Files 10-K Annual Report, Details Financial Performance and Risk Factors
Albertsons Companies, Inc. released its annual report on Form 10-K, providing a comprehensive overview of its business, financial results, and potential risks for the fiscal year ended February 24, 2024.
Worse than expected
Delay expected
Insider Trading (Form 4)
NYSE
Sharon Mccollam, President & CFO of Albertsons Companies, Inc., purchased 9,000 shares of common stock on July 31, 2026 for $11.48 per share.
NYSE
Susan Morris, Chief Executive Officer and a Director of Albertsons Companies, Inc., purchased 39,409 shares of common stock on July 28, 2026.
NYSE
Thomas M Moriarty, EVP, M&A and Corporate Affairs of Albertsons Companies, Inc., purchased 170,500 shares of common stock on July 27, 2026 for $11.51 per share.
NYSE
Albertsons Companies executive Michael Withers filed an amendment to correct an underreporting of 82 shares of Class A common stock.
NYSE
Chief Merchandising Officer Michelle Larson filed an amendment to correct an administrative error regarding share ownership.
NYSE
Albertsons Companies President and CFO Sharon McCollam filed an amendment to correct duplicate reporting of performance-based restricted stock units.
Proxy Statements (Def-14A)
NYSE
Albertsons Companies, Inc. issued a proxy statement supplement to correct an error regarding director attendance at fiscal 2024 board and committee meetings.
NYSE
Albertsons Companies, Inc. has filed a Definitive Proxy Statement (Schedule 14A) with the U.S. Securities and Exchange Commission.
NYSE
Albertsons Companies, Inc. announces a new era of growth under recently appointed CEO Susan Morris, outlining strategic pillars and a target of $1.5 billion in productivity savings by fiscal year 2027, despite missing its Adjusted EBITDA target for fiscal 2024.
Worse than expected
NYSE
Albertsons Companies, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
Albertsons Companies, Inc. has released its proxy statement detailing the agenda and proposals for its upcoming annual meeting of stockholders to be held virtually on August 8, 2024.
Schedule 13G - Passive Investments
NYSE
The Vanguard Group has amended its Schedule 13G filing for Albertsons Cos Inc, reporting 0% beneficial ownership following an internal realignment.
NYSE
The Vanguard Group reported a 7.16% beneficial ownership stake in Albertsons Cos Inc. common stock as of December 31, 2025.
NYSE
FMR LLC and Abigail P. Johnson report a 4.5% beneficial ownership in Albertsons Companies Inc. Class A Common Stock as of September 30, 2025.
NYSE
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a 6.8% beneficial ownership stake in Albertsons Cos Inc's Class A Common Stock as of June 30, 2025.
NYSE
FMR LLC and its affiliates have disclosed a 7.9% passive beneficial ownership stake in Albertsons Cos Inc., holding over 45 million shares of Class A Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.9% of Albertsons Companies, Inc.'s common stock as of March 31, 2025.